WIPO Members Conclude Year Positively With Copyright Committee, Despite No Changes To Text 14/12/2014 by Catherine Saez, Intellectual Property Watch 2 Comments The World Intellectual Property Organization’s last committee meeting of the year finished on an amiable note last week. The committee on copyright did not advance on text drafting but, according to the chair and a number of delegations, the weeklong meeting was an opportunity for extensive discussions on substance, the best in a long time.
Copyright Exceptions For Libraries: WIPO Should Step Up Before Someone Else Does, Researcher Says 12/12/2014 by Catherine Saez, Intellectual Property Watch 8 Comments The author of a World Intellectual Property Organization-commissioned study said this week that WIPO should take the lead on the issue of limitations and exceptions to copyright for libraries, before the debate and the solution are left to other actors.
EPO Supervisory Body To Face Fears Over Patent Quality, Judicial Independence 10/12/2014 by Dugie Standeford for Intellectual Property Watch 4 Comments As staff strikes continue and the European Patent Office’s Administrative Council prepares for what could be a contentious 11 December meeting, opinions are split over the effect of the turmoil on the office’s role in Europe’s unitary patent.
Limitations And Exceptions For Libraries, Archives And Education At WIPO: What To Know About The Africa Group Proposal 10/12/2014 by Intellectual Property Watch Leave a Comment The 29th Session of the Standing Committee on Copyright and Related Rights at the World Intellectual Property Organization is currently underway. On the agenda, inter alia, will be discussions on Limitations and Exceptions to Libraries, Archives and Educational, Teaching and Research Institutions. Against the backdrop of the success with the Marrakesh Treaty, the trajectory looks set for these further exceptions and limitations to succeed.
WIPO Seminar: For Access To Hepatitis C Treatments, Look At HIV Lessons 08/12/2014 by Catherine Saez, Intellectual Property Watch 2 Comments A seminar on innovation and access to medicine last week examined the issue of access to hepatitis C treatment, looking at the HIV/AIDS path. Voluntary licences, such as the one entered by Gilead for its hepatitis drugs, have been applauded but such licences often do not cover middle-income countries, which are home to the bulk of hepatitis C patients, and whose poor populations remain unable to access treatment.
Draft UN Post-2015 Development Goals: Future Must Not Be ‘Business As Usual’, Including IP Rights 07/12/2014 by William New, Intellectual Property Watch Leave a Comment Last week’s United Nations draft report for the post-2015 sustainable development goals under negotiation calls for continued progress toward sweeping improvements in the lives of all people and the health of the planet, including ensuring that intellectual property rights are respected but do not get in the way.
WIPO Seminar Discusses Intellectual Property And Gender 05/12/2014 by Elena Bourtchouladze for Intellectual Property Watch 1 Comment Gender differences persist in the field of intellectual property, but there are signs of change, and new proposals are emerging for bringing greater balance, a US professor told a gathering at the World Intellectual Property Organization this week.
Index: Pharma Industry Improves On Access To Medicines, Needs Work On Ethics, Patent Disclosure 17/11/2014 by William New, Intellectual Property Watch Leave a Comment The 2014 edition of an independent ranking of leading pharmaceutical companies’ efforts to help developing countries released today found new initiatives undertaken in the past two years. But it said corruption and insufficient disclosure of existing patents continue to plague the industry.
US IP Industry Meeting With Indian Judges A “Ruse”, Activists Say 17/11/2014 by Intellectual Property Watch 1 Comment Public health activists and others have been watching closely in recent months as United States government and industry officials meet steadily and intensively with Indian counterparts to press change in that country’s intellectual property policy toward greater protection and recognition of western IP rights. A particular area of concern has been in pharmaceuticals, as India is said to be the world’s top supplier of affordable generic versions of drugs under patent that otherwise would be out of reach for millions of poor patients. Several activists have raised alarm over a meeting this week of US IP industry representatives with top judges in India.
WHO Influenza Preparedness Report Shows Companies Not Fulfilling Obligations 14/11/2014 by Catherine Saez, Intellectual Property Watch Leave a Comment The World Health Organization Pandemic Influenza Preparedness (PIP) Framework is at risk due to some companies not fulfilling their obligations, a new WHO report says.